{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:04:38Z","timestamp":1760346278444},"reference-count":36,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1507\/endocrj.ej12-0111","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T15:05:13Z","timestamp":1340809513000},"page":"919-929","source":"Crossref","is-referenced-by-count":6,"title":["Irbesartan prevents myocardial remodeling in experimental thyrotoxic cardiomyopathy"],"prefix":"10.1507","volume":"59","author":[{"given":"Bo Hyun","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"},{"name":"Medical Research Institute, Pusan National University, Busan 602-739, Korea"},{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"},{"name":"Medical Research Institute, Pusan National University, Busan 602-739, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Im","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Maryknoll Medical Center, Busan 600-730, Korea"},{"name":"Department of Internal Medicine, Maryknoll Medical Center, Busan 600-730, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Man","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Maryknoll Medical Center, Busan 600-730, Korea"},{"name":"Department of Internal Medicine, Maryknoll Medical Center, Busan 600-730, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee-Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Pusan National University School of Medicine, Busan 602-739, Korea"},{"name":"Department of Pathology, Pusan National University School of Medicine, Busan 602-739, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Gwang","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"},{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hyun","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"},{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Kyung","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"},{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"},{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Jang","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"},{"name":"Department of Nuclear Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Ki","family":"Kim","sequence":"additional","affiliation":[{"name":"Kim Yong Ki Internal Medicine Clinic, Busan 602-011, Korea"},{"name":"Kim Yong Ki Internal Medicine Clinic, Busan 602-011, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Joo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"},{"name":"Medical Research Institute, Pusan National University, Busan 602-739, Korea"},{"name":"Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea"},{"name":"Medical Research Institute, Pusan National University, Busan 602-739, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. <i>J Clin Endocrinol Metab<\/i> 87:968-974.","DOI":"10.1210\/jcem.87.3.8302"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.678326"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kahaly GJ, Dillmann WH (2005) Thyroid hormone action in the heart. <i>Endocr Rev<\/i> 26:704-728.","DOI":"10.1210\/er.2003-0033"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Napoli R, Biondi B, Guardasole V, Matarazzo M, Pardo F, <i>et al.<\/i> (2001) Impact of hyperthyroidism and its correction on vascular reactivity in humans. <i>Circulation<\/i> 104:3076-3080.","DOI":"10.1161\/hc5001.100621"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1996.6.505"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1097\/01.SMJ.0000125100.10857.54"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Siu CW, Yeung CY, Lau CP, Kung AW, Tse HF (2007) Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. <i>Heart<\/i> 93:483-487.","DOI":"10.1136\/hrt.2006.100628"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Riaz K, Forker AD, Isley WL, Hamburg MS, McCullough PA (2003) Hyperthyroidism: a &ldquo;curable&ldquo; cause of congestive heart failure--three case reports and a review of the literature. <i>Congest Heart Fail<\/i> 9:40-46.","DOI":"10.1111\/j.1527-5299.2003.01124.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Degens H, Gilde AJ, Lindhout M, Willemsen PH, Van Der Vusse GJ, <i>et al.<\/i> (2003) Functional and metabolic adaptation of the heart to prolonged thyroid hormone treatment. <i>Am J Physiol Heart Circ Physiol<\/i> 284:H108-115.","DOI":"10.1152\/ajpheart.00282.2002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vydt T, Verhelst J, De Keulenaer G (2006) Cardiomyopathy and thyrotoxicosis: tachycardiomyopathy or thyrotoxic cardiomyopathy? <i>Acta Cardiol<\/i> 61(1):115-117.","DOI":"10.2143\/AC.61.1.2005149"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90533-J"},{"key":"12","unstructured":"12. Gerdes AM, Moore JA, Bishop SP (1985) Failure of propranolol to prevent chronic hyperthyroid induced cardiac hypertrophy and multifocal cellular necrosis in the rat. <i>Can J Cardiol<\/i> 1:340-345."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Klein I (1988) Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol. <i>Endocrinology<\/i> 123:203-210.","DOI":"10.1210\/endo-123-1-203"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kobori H, Ichihara A, Miyashita Y, Hayashi M, Saruta T (1999) Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. <i>J Endocrinol<\/i> 160:43-47.","DOI":"10.1677\/joe.0.1600043"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ichihara A, Kobori H, Miyashita Y, Hayashi M, Saruta T (1998) Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells. <i>Am J Physiol<\/i> 274:E224-231.","DOI":"10.1152\/ajpendo.1998.274.2.E224"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sernia C, Marchant C, Brown L, Hoey A (1993) Cardiac angiotensin receptors in experimental hyperthyroidism in dogs. <i>Cardiovasc Res<\/i> 27:423-428.","DOI":"10.1093\/cvr\/27.3.423"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kobori H, Ichihara A, Suzuki H, Miyashita Y, Hayashi M, <i>et al.<\/i> (1997) Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system. <i>Am J Physiol<\/i> 272:E227-232.","DOI":"10.1152\/ajpendo.1997.272.2.E227"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.105"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mintz G, Pizzarello R, Klein I (1991) Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. <i>J Clin Endocrinol Metab<\/i> 73:146-150.","DOI":"10.1210\/jcem-73-1-146"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nishikage T, Nakai H, Lang RM, Takeuchi M (2008) Subclinical left ventricular longitudinal systolic dysfunction in hypertension with no evidence of heart failure. <i>Circ J<\/i> 72:189-194.","DOI":"10.1253\/circj.72.189"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Becker M, Bilke E, Kuhl H, Katoh M, Kramann R, <i>et al.<\/i> (2006) Analysis of myocardial deformation based on pixel tracking in two dimensional echocardiographic images enables quantitative assessment of regional left ventricular function. <i>Heart <\/i>92:1102-1108.","DOI":"10.1136\/hrt.2005.077107"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.063"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cho KI, Lee JH, Lee HG, Kim SM, Kim TI (2010) Assessment of myocardial function in patients with fibromyalgia and the relationship to chronic emotional and physical stress. <i>Korean Circ J<\/i> 40:74-80.","DOI":"10.4070\/kcj.2010.40.2.74"},{"key":"24","unstructured":"24. Hu LW, Benvenuti LA, Liberti EA, Carneiro-Ramos MS, Barreto-Chaces LM (2003) Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. <i>Am J Physiol Regul Integr Comp Physiol<\/i> 285:R1473-1480."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bilezikian JP, Loeb JN (1983) The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness. <i>Endocr Rev<\/i> 4:378-388.","DOI":"10.1210\/edrv-4-4-378"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Moalic JM, Bourgeois F, Mansier P, Machida CA, Carre F, <i>et al<\/i>. (1993) Beta 1 adrenergic receptor and G alpha s mRNAs in rat heart as a function of mechanical load and thyroxine intoxication. <i>Cardiovasc Res<\/i> 27:231-237.","DOI":"10.1093\/cvr\/27.2.231"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111842"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Zierhut W, Zimmer HG (1989) Significance of myocardial &alpha; and &beta; adrenoceptors in catecholamine-induced cardiac hypertrophy. <i>Circ Res<\/i> 65: 1417-1425.","DOI":"10.1161\/01.RES.65.5.1417"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Asahi T, Shimabukuro M, Oshiro Y, Yoshida H, Takasu N (2001) Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats. <i>Thyroid<\/i> 11:1009-1015.","DOI":"10.1089\/105072501753271680"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Bruckschlegel G, Holmer SR, Jandeleit K, Grimm D, Muders F, <i>et al.<\/i> (1995) Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. <i>Hypertension<\/i> 25:250-259.","DOI":"10.1161\/01.HYP.25.2.250"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.3109\/10641968909038172"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1161\/hc3901.096700"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1994.1036"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35. Yao J, Eghbali M (1992) Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy. Response of cardiac fibroblasts to thyroid hormone in vitro. <i>Circ Res<\/i> 71:831-839.","DOI":"10.1161\/01.RES.71.4.831"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1097\/00001573-200007000-00010"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37. Crawford DC, Chobanian AV, Brecher, P (1994) Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. <i>Circ Res<\/i> 74:727-739.","DOI":"10.1161\/01.RES.74.4.727"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/59\/10\/59_EJ12-0111\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:31:17Z","timestamp":1618295477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/59\/10\/59_EJ12-0111\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej12-0111","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}